15th European Crohn's and Colitis Organisation Congress

Volume: 5, Issue: 4, Pages: 339 - 339
Published: Apr 1, 2020
Abstract
Jean-Frédéric Colombel (Icahn School of Medicine at Mount Sinai, New York, USA) and colleagues presented data from the maintenance phase of the SERENE-UC trial, which compared higher dose versus standard dose adalimumab maintenance regimens for patients with moderately to severely active ulcerative colitis. After completion of the randomised induction phase at week 8, patients were re-randomised to receive either adalimumab 40 mg every week,...
Paper Details
Title
15th European Crohn's and Colitis Organisation Congress
Published Date
Apr 1, 2020
Volume
5
Issue
4
Pages
339 - 339
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.